Good Outcome of Resective Epilepsy Surgery in a 1-Year-Old Child with Drug-Resistant Focal Epilepsy with a Novel Pathogenic COL4A1 Mutation
Neuropediatrics · 01.08.2024 · 55 (04) · 255-259
DOI: 10.1055/a-2236-7066 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropediatrics, erschienen am 01.08.2024. Verfasst von Nicholas Fearns und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital, Ludwig-Maximilian University (LMU) Munich, Munich, Germany. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Collagen Type IV, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Pathogenic variants in COL4A1, encoding the α chain of type IV collagen, have been associated with cerebrovascular pathology as well as malformations of cortical development, thereby causing structural epilepsy. This case illustrates successful resective epilepsy surgery in a 12-month-old girl with left occipital focal cortical dysplasia (FCD) associated with a heterozygous splice-donor variant in COL4A1. She presented with drug-resistant focal epilepsy with daily seizures from the age of 2 months, refractory to several combinations of antiseizure medications, as well as mild right-sided hemiparesis and developmental delay. All presurgical diagnostic modalities, including ictal and interictal electroencephalography, magnetic resonance imaging, and ictal fluorodeoxyglucose positron emission tomography, showed congruent findings, pointing toward one single left occipital epileptogenic zone (EZ). We performed a left occipital lobectomy, using intraoperative electrocorticography to confirm the boundaries of the EZ. After surgery, the patient has remained seizure free, and both cognitive and motor developments have improved. Histopathology of the resected brain tissue showed FCD type Ia. Resective epilepsy surgery can have a very good outcome, also in patients with genetic mutations in COL4A1, constituting a less invasive option than the previously used more radical surgical procedures such as hemispherectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Hospital, Ludwig-Maximilian University (LMU) Munich, Munich, Germany.
- Institute of Human Genetics, University Hospital rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
- Institute of Neurogenomics, Helmholtz Center Munich, Munich, Germany.
- Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig-Maximilian University (LMU) Munich, Munich, Germany.
- Department of Neurosurgery, University Hospital, Ludwig-Maximilian University (LMU) Munich, Munich, Germany.
ORCID-Profile: Nicholas Fearns
Zitieren
APA
Fearns, N., Wagner, M., Borggräfe, I., Kunz, M., Rémi, J., & Vollmar, C. (2024). Good Outcome of Resective Epilepsy Surgery in a 1-Year-Old Child with Drug-Resistant Focal Epilepsy with a Novel Pathogenic COL4A1 Mutation. Neuropediatrics, 55(04), 255-259. https://doi.org/10.1055/a-2236-7066
Vancouver
Fearns N, Wagner M, Borggräfe I, Kunz M, Rémi J, Vollmar C. Good Outcome of Resective Epilepsy Surgery in a 1-Year-Old Child with Drug-Resistant Focal Epilepsy with a Novel Pathogenic COL4A1 Mutation. Neuropediatrics. 2024;55(04):255-259. doi:10.1055/a-2236-7066
BibTeX
@article{Fearns2024,
author = {Fearns, Nicholas and Wagner, Matias and Borggräfe, Ingo and Kunz, Mathias and Rémi, Jan and Vollmar, Christian},
title = {Good Outcome of Resective Epilepsy Surgery in a 1-Year-Old Child with Drug-Resistant Focal Epilepsy with a Novel Pathogenic COL4A1 Mutation},
journal = {Neuropediatrics},
year = {2024},
volume = {55},
number = {04},
pages = {255--259},
doi = {10.1055/a-2236-7066}
}
EUVIMED